Ratan Tata to lay foundations for a 300 bed cancer hospital in Ranchi

Ratan Tata, the chairman emeritus of Tata Sons and the chairman of Tata Trusts, will lay the foundations for a the hospital cum research center on Saturday.

The hospital will come up on 23 acres of land donated by the state department of health, medical education and family welfare department to the Tata Trusts in Kanke on the outskirts of the state capital earlier this year.

Jharkhand health secretary Nitin Madan Kulkarni said the first phase of the hospital is expected to become operational with 150 beds by 2022. “Once operational, it will cater to thousands of cancer patients of Jharkhand who visit different states for treatment every year,” Kulkarni added.

The groundbreaking comes less than a week before Jharkhand is due to observe the 18th statehood day.

State government had said seeds of the hospital were sown during the inaugural session of the Momentum Jharkhand Global Investment Summit held in February 2017 when Jharkhand chief minister Raghubar Das approached Tata and floated the idea of building a cancer care center, which the latter agreed to.

With Jharkhand lacking a robust cancer treatment infrastructure in its state run tertiary and secondary healthcare centers, the health department has approached the Tata Trusts to handhold in setting up screening facilities in government healthcare centers.

  • Related Posts

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    In a Trailblazing approach, Aakash Healthcare Surgeons rebuilt Children’s Lower Limbs using Mothers’ Bone New Delhi: A 16-year-old girl whose thigh bone was destroyed by chronic infection in 2021 is…

    Safdarjung Hospital performs its first dual kidney transplant using organs from marginal donor

    The Indian Air Force airlifted the retrieved organs to Delhi from Command Hospital, Chandimandir, where the 62-year-old donor was declared brain dead. New Delhi: Vardhman Mahavir Medical College (VMMC) and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction